Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

August 24, 2017

Primary Completion Date

March 6, 2020

Study Completion Date

June 30, 2020

Conditions
Heart Failure
Interventions
DEVICE

Hemodynamic management using CardioMEMS HF System

Using the CardioMEMS HF System, clinicians will treat to target PA pressure ranges

Trial Locations (23)

10032

New York-Presbyterian/Columbia University Medical Center, New York

11030

North Shore University Hospital, Manhasset

11576

St. Francis Hospital, Roslyn

14642

University of Rochester Medical Center, Rochester

27607

University of North Carolina at Chapel Hill, Chapel Hill

University of North Carolina, Raleigh

29203

Palmetto Health Richland, Columbia

40536

University of Kentucky, Lexington

43210

Ohio Sate University, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

44195

The Cleveland Clinic Foundation, Cleveland

48109

University of Michigan, Ann Arbor

53215

Aurora Medical Center, Milwaukee

55455

University of Minnesota, Minneapolis

68105

The Nebraska Medical Center, Omaha

77030

The Methodist Hospital, Houston

84132

University of Utah Hospital, Salt Lake City

90033

USC University Hospital, Los Angeles

90095

Ronald Reagan UCLA Medical Center, Los Angeles

92037

Scripps Health, La Jolla

92123

San Diego Cardiac, San Diego

94109

California Pacific Medical Center - Van Ness Campus, San Francisco

97225

Providence Heart and Vascular Institute, Portland

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT03247829 - Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™ | Biotech Hunter | Biotech Hunter